Search research articles
Contact Us
Filters
Showing results (51-60 of 190) with videos related to
Page
of 19
Sort By:
Journal of Clinical Psychopharmacology
|
April 8, 2025
Navacaprant, a Novel and Highly Selective Kappa Opioid Receptor Antagonist, in Adults With Major Depressive Disorder: A Randomized, Double-Blind Phase 2 Clinical Trial
Sanjay J Mathew, Andrew J Cutler, Nicole C Visitacion, et al.
Annals of the New York Academy of Sciences
|
February 5, 2015
The promise of ketamine for treatment-resistant depression: current evidence and future directions
Kaitlin E DeWilde, Cara F Levitch, James W Murrough, et al.
Journal of Affective Disorders
|
August 29, 2018
Serum and plasma brain-derived neurotrophic factor and response in a randomized controlled trial of riluzole for treatment resistant depression
Samuel T Wilkinson, Carly Kiselycznyk, Mounira Banasr, et al.
Advances in Neurobiology
|
March 17, 2023
Biomarkers in Psychiatric Drug Development: From Precision Medicine to Novel Therapeutics
Rudy Lozano Carreon, Ana Maria Rivas-Grajales, Nicholas Murphy, et al.
Journal of Psychopharmacology (Oxford, England)
|
August 15, 2014
Hippocampal volume and the rapid antidepressant effect of ketamine
Chadi G Abdallah, Ramiro Salas, Andrea Jackowski, et al.
Translational Psychiatry
|
July 4, 2026
High-order brain interactions during ketamine-induced state changes: A functional marker of response in late-life treatment-resistant depression?
Krisha Shah, Rubén Herzog, Alan C Swann, et al.
CNS Drugs
|
February 7, 2012
Ketamine for treatment-resistant unipolar depression: current evidence
Sanjay J Mathew, Asim Shah, Kyle Lapidus, et al.
CNS Drugs
|
July 28, 2010
Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists
John H Krystal, Sanjay J Mathew, D Cyril D'Souza, et al.
The International Journal of Neuropsychopharmacology
|
November 29, 2020
Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression
Ana Maria Rivas-Grajales, Ramiro Salas, Meghan E Robinson, et al.
Bipolar Disorders
|
February 15, 2012
Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial
Amit Anand, Abigail D Gunn, Gavriel Barkay, et al.
Page
of 19
Search research articles
Search
Showing results (51-60 of 190) with videos related to
Sort By:
Page
of 19
Journal of Clinical Psychopharmacology
|
April 8, 2025
Navacaprant, a Novel and Highly Selective Kappa Opioid Receptor Antagonist, in Adults With Major Depressive Disorder: A Randomized, Double-Blind Phase 2 Clinical Trial
Sanjay J Mathew, Andrew J Cutler, Nicole C Visitacion, et al.
Annals of the New York Academy of Sciences
|
February 5, 2015
The promise of ketamine for treatment-resistant depression: current evidence and future directions
Kaitlin E DeWilde, Cara F Levitch, James W Murrough, et al.
Journal of Affective Disorders
|
August 29, 2018
Serum and plasma brain-derived neurotrophic factor and response in a randomized controlled trial of riluzole for treatment resistant depression
Samuel T Wilkinson, Carly Kiselycznyk, Mounira Banasr, et al.
Advances in Neurobiology
|
March 17, 2023
Biomarkers in Psychiatric Drug Development: From Precision Medicine to Novel Therapeutics
Rudy Lozano Carreon, Ana Maria Rivas-Grajales, Nicholas Murphy, et al.
Journal of Psychopharmacology (Oxford, England)
|
August 15, 2014
Hippocampal volume and the rapid antidepressant effect of ketamine
Chadi G Abdallah, Ramiro Salas, Andrea Jackowski, et al.
Translational Psychiatry
|
July 4, 2026
High-order brain interactions during ketamine-induced state changes: A functional marker of response in late-life treatment-resistant depression?
Krisha Shah, Rubén Herzog, Alan C Swann, et al.
CNS Drugs
|
February 7, 2012
Ketamine for treatment-resistant unipolar depression: current evidence
Sanjay J Mathew, Asim Shah, Kyle Lapidus, et al.
CNS Drugs
|
July 28, 2010
Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists
John H Krystal, Sanjay J Mathew, D Cyril D'Souza, et al.
The International Journal of Neuropsychopharmacology
|
November 29, 2020
Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression
Ana Maria Rivas-Grajales, Ramiro Salas, Meghan E Robinson, et al.
Bipolar Disorders
|
February 15, 2012
Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial
Amit Anand, Abigail D Gunn, Gavriel Barkay, et al.
Page
of 19